prehensive neurological assess ment, and cerebral MRI. The interview included a standard question about whether, when, and why cycling had become impossible. The gold standard was the diagnosis after 3 years, which was based on the clinical follow-up including repeat neurological examination, response to treatment, and MRI. All assessments were done by a single, experienced examiner. All patients gave informed consent, as approved by the local ethics committee.
Before their fi rst disease manifestation, 111 patients rode a bicycle (table) . 45 went on to develop a goldstandard diagnosis of Parkinson's disease and 64 a form of atypical parkinsonism. At the time of inclusion (median disease duration 30 months), 34 of the 64 patients with atypical parkinsonism had stopped cycling, as opposed to only two of the 45 patients with Parkinson's disease (sensitivity 52%, specifi city 96%; AUC 0·74, 95% CI 0·64-0·83). The loss of cycling abilities was present for all forms of atypical parkinsonism. Regression analysis revealed no signifi cant eff ect of age, parkinsonism, or ataxia on the ability to cycle, suggesting that this was an independent marker of atypical parkinsonism.
We suggest that loss of the ability to cycle after disease onset might serve as a new red fl ag, signalling the presence of atypical parkinsonism. The diagnostic value of the "bicycle sign" was good: its presence was highly specifi c for the diagnosis of atypical parkinsonism. In table 1, the data in parentheses for coma depth are IQR. The last line of the legend for fi gure 3 should have read: "I² denotes the percentage of total variation across subgroups resulting from heterogeneity rather than chance, with the p value of signifi cance". The title of fi gure 5 should have read: "Meta-analysis of all randomised controlled trials that have compared mortality of severe malaria in patients treated with parenteral artesunate versus parenteral quinine 12-16 ". These corrections have been made to the online version as of Jan 7, 2011. 
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